Iodides

solute carrier family 5 member 5 ; Homo sapiens







185 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 22355179 Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells. 2012 Jun 1
52 22750642 The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics. 2012 Sep 3
53 22962269 Iodide transporter NIS regulates cancer cell motility and invasiveness by interacting with the Rho guanine nucleotide exchange factor LARG. 2012 Nov 1 1
54 23037808 A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. 2012 Dec 2
55 23181221 Progress in gene therapy for prostate cancer. 2012 1
56 20479570 Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein. 2011 Mar 3
57 21085047 Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS. 2011 Feb 3
58 21209020 KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. 2011 Mar 1
59 21499816 Expression and localization of the sodium/iodide symporter (NIS) in testicular cells. 2011 Aug 2
60 21565787 Iodide transport defect: functional characterization of a novel mutation in the Na+/I- symporter 5'-untranslated region in a patient with congenital hypothyroidism. 2011 Jul 4
61 21702220 Radioiodide uptake and sodium iodide symporter expression in breast carcinoma. 2011 Jun 1
62 21797672 Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. 2011 Aug 3
63 21801606 Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells. 2011 Aug 1
64 21989294 Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer. 2011 Oct 11 2
65 22220168 Evaluation of lentiviral-mediated expression of sodium iodide symporter in anaplastic thyroid cancer and the efficacy of in vivo imaging and therapy. 2011 1
66 19618116 Breast cancer brain metastases express the sodium iodide symporter. 2010 Feb 1
67 20053774 Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model. 2010 Jan 1
68 20123735 Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription. 2010 Jun 1
69 20228127 Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. 2010 Jun 2
70 20428214 A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. 2010 Nov 1
71 20577737 Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter. 2010 Nov 2
72 20681442 [Study on the iodine 125 uptake of H460 lung cancer cell line by co-transfection with the human sodium/iodide symporter and the human thyroperoxidase]. 2010 Jun 3
73 24899932 Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. 2010 Apr 1
74 18500672 Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? 2009 May 2
75 19029227 Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers. 2009 Feb 2
76 19098211 Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. 2009 Jan 1
77 19196800 Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. 2009 Mar 7
78 19241193 AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. 2009 Jul 1
79 19331152 Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA). 2009 Jan 1
80 19525464 Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells. 2009 Jul 1
81 19780099 Synthesis and evaluation of imidazo[2,1-b]thiazoles as iodide efflux inhibitors in thyrocytes. 2009 Nov 2
82 18202121 Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer. 2008 May 2
83 18283639 Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 2008 May 2
84 18307189 Small-molecule inhibitors of sodium iodide symporter function. 2008 Apr 14 2
85 18372236 Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization. 2008 Apr 1
86 18404268 The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. 2008 Jul 1
87 18470848 Enhanced iodide sequestration by 3-biphenyl-5,6-dihydroimidazo[2,1-b]thiazole in sodium/iodide symporter (NIS)-expressing cells. 2008 Aug 5
88 18708479 Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter. 2008 Nov 8
89 17214887 Expression of the Na+/I- symporter (NIS) is markedly decreased or absent in gastric cancer and intestinal metaplastic mucosa of Barrett esophagus. 2007 Jan 10 1
90 17266027 MIDGE/hNIS vaccination generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity. 2007 May 1 1
91 17611400 In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter. 2007 Jul 2
92 17639055 MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner. 2007 Jun 2
93 17695547 Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter. 2007 Jul-Aug 1
94 17696829 hNIS protein in thyroid: the iodine supply influences its expression and localization. 2007 Jul 1
95 17698909 Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. 2007 Nov 3
96 17891230 The importance of sodium/iodide symporter (NIS) for thyroid cancer management. 2007 Jul 1
97 17912014 In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter. 2007 1
98 17913707 Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter. 2007 Dec 21 4
99 17931047 Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. 2007 Oct 1
100 18167272 [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells]. 2007 Oct 23 1